Type of Study:
Type 2 diabetes patients who are between 10 to 17 years
10 – 17 years, Male and Female
Participants will receive at no cost: study product, study materials and study-specific procedures
This study will assess how well empagliflozin and linagliptin work in children and adolescents(DINAMO).